TMTlaleo Azael Marole

Tlaleo Azael Marole

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tlaleo Azael Marole has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioactive metabolite profiling in mixed-species probiotic yogurt

    by Tlaleo A. Marole, Thulani Sibanda, Elna M. Buys

    Yogurt consumption is a natural way of accessing bioactive metabolites such as peptides and short-chain fatty acids (SCFA). Proteolytic systems and metabolic pathways of lactic acid bacteria (LAB) and probiotics, which differ among the species, influence bioactive metabolite profiles in yogurt. This study determined the bioactive peptide and SCFA profiles in mixed-species yogurt incorporating Bifidobacterium bifidum ATCC 11863, Bifidobacterium breve ATCC 15700, Bifidobacterium animalis ssp. animalis ATCC 25527, and Lacticaseibacillus rhamnosus GG using ultra-performance liquid chromatography coupled to electrospray ionization quadrupole-time-of-flight MS and GC-MS, respectively. Significantly higher proteolytic activities were observed in yogurt incorporating either probiotic species of B. bifidum ATCC 11863 or L. rhamnosus GG. Yogurt incorporating B. bifidum ATCC 11863 contained more peptides with higher bioactivity. Bifidobacterium animalis ssp. animalis ATCC 25527 significantly enhanced the SCFA content (acetic acid) in yogurt. Whereas L. rhamnosus GG increased the production of both bioactive peptides and SCFA in yogurt when incorporated as a monoculture or coculture with B. bifidum ATCC 11863 and B. animalis ssp. animalis ATCC 25527, respectively. Novel short peptides (<10 AA) derived from minor milk serum proteins with potential antimicrobial properties were identified in the different probiotic yogurts. This study provides insights into the bioactive metabolite profiles of yogurt incorporating probiotics, L. rhamnosus and Bifidobacterium spp., and their role in developing yogurt with enhanced therapeutic benefits.


  • Open Access

    Assessing probiotic viability in mixed species yogurt using a novel propidium monoazide (PMAxx)-quantitative PCR method

    by Tlaleo A. Marole, Thulani Sibanda, Elna M. Buys

    Viability is a prerequisite for any therapeutic benefits associated with the ingestion of probiotic bacteria. Current culture-based techniques are inadequate for the enumeration of probiotics in mixed-species food products. This study utilized a quantitative PCR (qPCR) method coupled with propidium monoazide (PMAxx), and novel species-specific tuf gene primers to selectively enumerate Lacticaseibacillus rhamnosus, Bifidobacterium spp., and yogurt starter cultures in mixed-species probiotic yogurt. The method was optimized for PMAxx concentration and specificity and evaluated for efficiency and applicability. PMAxx-qPCR showed high specificity to the target organisms in mixed-species yogurt, quantifying only viable cells. The linear dynamic ranges were established over five to seven orders of magnitude. The assay was reliable with an efficiency of 91–99%, R2 values > 0.99, and a good correlation to the plate count method (r = 0.882). The results of this study demonstrate the high selectivity, improved lead time, and reliability of PMAxx-qPCR over the culture-dependent method, making it a valuable tool for inline viability verification during processing and improving probiotic quality assurance for processors and consumers.


  • Top Cited Papers
    Open Access

    Bifidobacterium species viability in dairy-based probiotic foods: challenges and innovative approaches for accurate viability determination and monitoring of probiotic functionality

    by Thulani Sibanda, Tlaleo Azael Marole, Ursula Louise Thomashoff, Mapitsi S. Thantsha, Elna M. Buys

    Bifidobacteriumspecies are essential members of a healthy human gut microbiota. Their presence in the gut is associated with numerous health outcomes such as protection against gastrointestinal tract infections, inflammation, and metabolic diseases. Regular intake ofBifidobacteriumin foods is a sustainable way of maintaining the health benefits associated with its use as a probiotic. Owing to their global acceptance, fermented dairy products (particularly yogurt) are considered the ideal probiotic carrier foods. As envisioned in the definition of probiotics as “live organisms,” the therapeutic functionalities ofBifidobacteriumspp. depend on maintaining their viability in the foods up to the point of consumption. However, sustainingBifidobacteriumspp. viability during the manufacture and shelf-life of fermented dairy products remains challenging. Hence, this paper discusses the significance of viability as a prerequisite forBifidobacteriumspp. probiotic functionality. The paper focuses on the stress factors that influenceBifidobacteriumspp. viability during the manufacture and shelf life of yogurt as an archetypical fermented dairy product that is widely accepted as a delivery vehicle for probiotics. It further expounds theBifidobacteriumspp. physiological and genetic stress response mechanisms as well as the methods for viability retention in yogurt, such as microencapsulation, use of oxygen scavenging lactic acid bacterial strains, and stress-protective agents. The report also explores the topic of viability determination as a critical factor in probiotic quality assurance, wherein, the limitations of culture-based enumeration methods, the challenges of species and strain resolution in the presence of lactic acid bacterial starter and probiotic species are discussed. Finally, new developments and potential applications of next-generation viability determination methods such as flow cytometry, propidium monoazide–quantitative polymerase chain reaction (PMA-qPCR), next-generation sequencing, and single-cell Raman spectroscopy (SCRS) methods are examined.